What are the clinical implications of a chronically low hemoglobin A1c (3.9%) in a non‑diabetic patient who is not taking insulin or oral hypoglycemic agents?

Clinical Implications of Chronically Low A1C (3.9%) in a Non-Diabetic Patient

A chronically low A1C of 3.9% in a non-diabetic patient not on hypoglycemic medications is abnormal and warrants immediate investigation for conditions affecting red blood cell turnover or hemoglobin glycation, as this level is associated with increased all-cause mortality and likely reflects underlying pathology rather than true hypoglycemia.

Primary Diagnostic Considerations

Investigate conditions that alter A1C independently of glycemia, as marked discordance between A1C and actual glucose levels indicates the A1C assay may not be reliable 1:

Conditions Causing Falsely Low A1C

• Increased red blood cell turnover is the most common cause of inappropriately low A1C 1:

  • Hemolytic anemia 1, 2
  • Recent blood loss or transfusion 1
  • Hemoglobinopathies (sickle cell disease, G6PD deficiency) 1
  • Reticulocytosis (>100 G/L suggests accelerated RBC turnover) 2

• Hepatic disease is strongly associated with low A1C levels 2:

  • Cirrhosis from various etiologies was present in 10/17 patients with A1C <4% in one study 2
  • Abnormal liver function tests (elevated transaminases, ferritin) commonly accompany low A1C 2

• Hemoglobin variants can interfere with A1C measurement 1:

  • African Americans with HbS trait may have A1C 0.3% lower than actual glycemia 1
  • G6PD G202A variant can decrease A1C by 0.7-0.8% 1

Mortality Risk Assessment

An A1C <4.0% is independently associated with increased all-cause mortality even after adjusting for multiple confounders 3:

• Hazard ratio of 2.90 (95% CI: 1.25-6.76) for all-cause mortality compared to A1C 5.0-5.4% 3
• This association persisted after adjustment for cardiovascular factors, metabolic factors, red blood cell indices, iron storage, and liver function 3
• Patients with A1C <4.0% had the highest mean red blood cell volume, ferritin, and liver enzymes 3

Required Workup Algorithm

Confirm the A1C result is not a laboratory artifact by using an NGSP-certified assay without hemoglobin variant interference 1:

1. Measure plasma glucose levels (fasting and/or 2-hour post-glucose load) to assess actual glycemic status 1

   • If glucose levels are normal, A1C does not reflect true glycemia 1

2. Complete blood count with reticulocyte count 2:

   • Hemoglobin <100 g/L suggests anemia 2
   • Reticulocytosis >100 G/L indicates increased RBC turnover 2
   • Elevated MCV suggests hemolysis or liver disease 3, 2

3. Hemoglobin electrophoresis to identify variants 1

4. Liver function panel (AST, ALT, bilirubin, albumin, ferritin) 3, 2:

   • Elevated transaminases and ferritin common with low A1C 3, 2

5. Iron studies and markers of hemolysis (LDH, haptoglobin, indirect bilirubin) 2

6. Consider alternative glycemic markers if A1C is unreliable 2:

   • Fructosamine or glycated albumin 1
   • Continuous glucose monitoring if hypoglycemia is suspected 1

Management Implications

Do not rely on A1C for any clinical decisions in this patient 1:

• Use only plasma glucose criteria for any diabetes-related assessments 1
• In conditions with increased RBC turnover, A1C should be abandoned entirely as a monitoring tool 1

Investigate for true hypoglycemia only if clinically indicated 2:

• True hypoglycemic periods are rare causes of chronically low A1C 2
• Consider insulinoma or congenital hyperinsulinism only if documented low glucose levels occur 2
• Most cases reflect altered erythrocyte lifespan or glycation process rather than hypoglycemia 2

Common Pitfalls to Avoid

• Do not assume the patient has excellent glycemic control based solely on the low A1C 1
• Do not overlook serious underlying conditions such as cirrhosis, hemolytic anemia, or hemoglobinopathies that require specific treatment 3, 2
• Do not use A1C for diabetes screening in this patient going forward 1
• Do not dismiss the finding as benign—the mortality association demands thorough evaluation 3